SAN FRANCISCO (AP) — Prescription drug distributor McKesson Corp. said Monday that it agreed to buy Med3000, a health care management and technology service company. Med3000 helps physician groups ...

FM71 Trial Design FM71 is a multi-center, randomized, open-label, home use, parallel group, clinical investigation of topically-applied MED3000 gel compared to oral tadalafil (5mg) tablets for the ...

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), the pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® technology, today ...

Update on a milestone year of regulatory and commercial progress for MED3000 Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its ...

Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on ...

Futura Announces Collaboration with Cooper Consumer Health to Commercialise MED3000 in EEA, United Kingdom and Switzerland Futura Medical plc (AIM: FUM), a pharmaceutical company developing a ...

- Company also announced that it raised proceeds of £4,375,000 to fund future commercialization of MED3000 via a warrant exercise by a large institutional shareholder - Futura Medical plc (AIM: FUM) ( ...

Hampson sees his work force as not only 1,700 employees, but 1,700 families, 1,700 mortgage payments and probably close to 4,000 family members. “That’s the most rewarding part of the business,” he ...

SAN FRANCISCO (AP) -- Prescription drug distributor McKesson Corp. said Monday that it agreed to buy Med3000, a health care management and technology service company. Med3000 helps physician groups ...